Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reduction in polypharmacy for epilepsy.

S D Shorvon, E H Reynolds

    British Medical Journal
    |October 27, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Reducing anticonvulsant polypharmacy in chronic epilepsy patients improved seizure control and mental function in over half of participants. However, withdrawal can be challenging, especially for those with frequent seizures or neuropsychological handicaps.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anglo-French neurological interactions in the 19th and early 20th centuries: Societies and Journals.

    Revue neurologique·2022
    Same author

    Anglo-French neurological interactions in the 19th and early 20th centuries: Physicians, places and events.

    Revue neurologique·2021
    Same author

    Allbutt of Leeds and Duchenne de Boulogne: Newly discovered insights on Duchenne by a British neuropsychiatrist.

    Revue neurologique·2018
    Same author

    Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.

    Journal of neurology·2017
    Same author

    A brief history of hysteria: From the ancient to the modern.

    Handbook of clinical neurology·2016
    Same author

    What is the safe upper intake level of folic acid for the nervous system? Implications for folic acid fortification policies.

    European journal of clinical nutrition·2016

    Area of Science:

    • Neurology
    • Clinical Pharmacy
    • Epileptology

    Background:

    • Chronic epilepsy management often involves polypharmacy.
    • Anticonvulsant polypharmacy presents challenges in efficacy and patient management.
    • Reducing medication complexity is a key therapeutic goal.

    Purpose of the Study:

    • To investigate the feasibility and outcomes of reducing anticonvulsant polypharmacy in adult outpatients with chronic epilepsy.
    • To assess the impact of single-drug therapy on seizure control and mental function.
    • To identify factors influencing successful polypharmacy reduction.

    Main Methods:

    • A two-year prospective study involving 40 adult outpatients with chronic epilepsy.
    • Monitoring of blood drug concentrations.

    Related Experiment Videos

  • Systematic reduction of polypharmacy to single-drug treatment in eligible patients.

    • Main Results:

    • Polypharmacy was successfully reduced to single-drug treatment in 29 patients (72%).
    • Seizure control improved in 55% and mental function in 55% of patients post-reduction.
    • Seizure exacerbation during withdrawal was a primary reason for failure, particularly in complex cases.

    Conclusions:

    • Reducing anticonvulsant polypharmacy is feasible and can improve seizure control and mental function in a majority of epilepsy patients.
    • The withdrawal phase requires careful management to mitigate seizure exacerbation.
    • Avoiding polypharmacy initiation may be more effective than later reduction efforts.